Previous studies have demonstrated that CCND1 G870A polymorphism is significantly associated with the development of various cancers, such as breast cancer, prostate cancer, colorectal cancer, and other cancer types [21-25]. This evidence concerns the gene CCND1 and prostate carcinoma.